Have We Changed the Outcome in Membranous Nephropathy : A Propensity Study on the Role of Immunosuppressive Therapy
Clinical Journal of the American Society of Nephrology, 07/11/2011Cattran DC et al.
The study confirms that patient presenting characteristics and management regimens have changed significantly over time and the natural history of membranous nephropathy (MGN) has been altered. A study of propensity–matched patients confirms that current recommendations for immunosuppressive therapy (IS) have improved outcomes in MGN patients at high risk of progression.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.